Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gynecology

  Free Subscription

21.10.2024

2 Acta Obstet Gynecol Scand
7 Am J Obstet Gynecol
3 BMC Cancer
1 BMJ
1 Br J Cancer
1 Br J Radiol
1 Cancer
1 Cancer Res
3 Clin Cancer Res
12 Eur J Obstet Gynecol Reprod Biol
5 Fertil Steril
3 Gynecol Endocrinol
4 Gynecol Oncol
3 Int J Cancer
11 Int J Gynaecol Obstet
1 Int J Radiat Oncol Biol Phys
2 J Clin Endocrinol Metab
2 J Clin Oncol
1 JAMA
4 Lancet
5 Obstet Gynecol
3 Oncogene
2 PLoS One
2 Proc Natl Acad Sci U S A



    Acta Obstet Gynecol Scand

  1. KRONELD L, Polo-Kantola P, Ollila MM, Arffman RK, et al
    Chronotypes in middle-aged women with polycystic ovary syndrome: A population-based study.
    Acta Obstet Gynecol Scand. 2024 Oct 18. doi: 10.1111/aogs.14991.
    >> Share

  2. MACEDO ARANTES R, Ejzenberg D, Tanigawa RY, da Silva Neto AB, et al
    Analysis of two reperfusion techniques in uterine transplantation in an experimental model.
    Acta Obstet Gynecol Scand. 2024 Oct 14. doi: 10.1111/aogs.14979.
    >> Share


    Am J Obstet Gynecol

  3. CHAU MN, Dang VQ, Nguyen TC, Vu AT, et al
    Cervical pessary versus vaginal progesterone in individuals with a singleton pregnancy and a short cervix: a randomized controlled trial.
    Am J Obstet Gynecol. 2024 Oct 17:S0002-9378(24)01066.
    >> Share

  4. NITERT MD, Eccles-Smith J, Barrett HL
    Exploring the Impact of Pre-pregnancy Weight Loss Surgery on Pregnancy and Offspring Outcomes: a response.
    Am J Obstet Gynecol. 2024 Oct 17:S0002-9378(24)01078.
    >> Share

  5. YANG M, Xu L, Peng J
    Exploring the Impact of Pre-pregnancy Weight Loss Surgery on Pregnancy and Offspring Outcomes.
    Am J Obstet Gynecol. 2024 Oct 17:S0002-9378(24)01077.
    >> Share

  6. ECCLES-SMITH J, Nitert MD, McInytre HD, Barrett HL, et al
    Pre-pregnancy bariatric surgery: pregnancy and offspring outcomes: a response.
    Am J Obstet Gynecol. 2024 Oct 17:S0002-9378(24)01072.
    >> Share

  7. TAHERMANESH K, Allahqoli L, Karimzadeh A, Zeidi SN, et al
    Cesarean Scar niche: Comparison of Transvaginal Ultrasound Findings and Uterine Tissue Samples after Hysterectomy.
    Am J Obstet Gynecol. 2024 Oct 16:S0002-9378(24)01068.
    >> Share

  8. MEYER R, Hamilton KM, Schneyer R, Levin G, et al
    Short term outcomes of minimally invasive total versus supracervical hysterectomy for uterine fibroids: a NSQIP study.
    Am J Obstet Gynecol. 2024 Oct 14:S0002-9378(24)01054.
    >> Share

  9. SARKER MR, Ramos GA, Hull AD
    Recommending maternal bedrest to improve intrauterine growth is not proven.
    Am J Obstet Gynecol. 2024 Oct 2:S0002-9378(24)01043.
    >> Share


    BMC Cancer

  10. YIRSAW AN, Tefera M, Bogale EK, Anagaw TF, et al
    Applying the Health Belief Model to cervical cancer screening uptake among women in Ethiopia: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:1294.
    >> Share

  11. TURNA M, Rzazade R, Kucukmorkoc E, Kucuk N, et al
    Dose escalation with stereotactic body radiotherapy for cervical cancer treatment.
    BMC Cancer. 2024;24:1281.
    >> Share

  12. ZHAO JJ, Zhao J, Lin F, Xu LL, et al
    A quinoline-2-thione derivative as a novel chemotherapy drug candidate displays anti-tumor activity in vitro and in vivo.
    BMC Cancer. 2024;24:1272.
    >> Share


    BMJ

  13. WISE J
    Blood clots are leading cause of death during pregnancy, report shows.
    BMJ. 2024;387:q2252.
    >> Share


    Br J Cancer

  14. ZAHID MU, Waguespack M, Harman RC, Kercher EM, et al
    Fractionated photoimmunotherapy stimulates an anti-tumour immune response: an integrated mathematical and in vitro study.
    Br J Cancer. 2024;131:1378-1386.
    >> Share


    Br J Radiol

  15. CHEN XY, Zhang MZ, Wang JK, Li B, et al
    Post-Uterine Artery Embolization: 3-Day MRI Changes and Their Predictive Value for Therapeutic Efficacy in Symptomatic Uterine Fibroids.
    Br J Radiol. 2024 Oct 18:tqae213. doi: 10.1093.
    >> Share


    Cancer

  16. WILSON EM, Huang R, Jones KD, Hagemann IS, et al
    Challenges in implementation of molecular classification in early stage endometrial cancer-An NRG Oncology cooperative group mixed-methods study.
    Cancer. 2024 Oct 17. doi: 10.1002/cncr.35596.
    >> Share


    Cancer Res

  17. DA COSTA AA, Somuncu O, Ravindranathan R, Mukkavalli S, et al
    Single-Stranded DNA Gap Accumulation Is a Functional Biomarker for USP1 Inhibitor Sensitivity.
    Cancer Res. 2024;84:3435-3446.
    >> Share


    Clin Cancer Res

  18. BRAVO MELGAR J, Laoui D
    Chemotherapy Sparks Tertiary Lymphoid Structures in Metastatic Ovarian Cancer.
    Clin Cancer Res. 2024 Oct 18. doi: 10.1158/1078-0432.CCR-24-2738.
    >> Share

  19. CHAE YK, Othus M, Patel SP, Wilkinson KJ, et al
    SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors (DART): Non-Epithelial Ovarian Cancer.
    Clin Cancer Res. 2024 Oct 17. doi: 10.1158/1078-0432.CCR-24-0606.
    >> Share

  20. SOBERANIS PINA P, Clemens K, Bubie A, Grant B, et al
    Genomic landscape of circulating tumor DNA and real-world outcomes in advanced endometrial cancer.
    Clin Cancer Res. 2024 Oct 17. doi: 10.1158/1078-0432.CCR-24-2105.
    >> Share


    Eur J Obstet Gynecol Reprod Biol

  21. IRAOLA E, Menard JP, Baranne ML, Cudonnec J, et al
    Uptake of gynecological consultation following domestic or sexual violence: A case-control study in the context of induced abortion.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:22-27.
    >> Share

  22. TUMELTY ME, Spain E, Cheema A, Cinnamond K, et al
    The impact of the current medico-legal and regulatory culture in Ireland on the decision of graduate entry medical school students to pursue a career in obstetrics and gynecology.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:42-47.
    >> Share

  23. NG VWY, Seto MTY, Cheung KW
    Multidisciplinary care to optimise pregnancy outcomes among Jehovah's Witness: Case series over fifteen years in a tertiary teaching hospital.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:53-56.
    >> Share

  24. SORRENTI S, Khalil A, Giancotti A, Zullo F, et al
    Outcomes of twin pregnancies complicated by prelabor rupture of membranes before 26 weeks of gestation: systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:70-77.
    >> Share

  25. AMIN Z, Wilson C, Offiah I, Puckett M, et al
    A feasibility study of magnetic resonance pelvimetry in women of short stature to identify the risk of cephalo-pelvic disproportion.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:78-84.
    >> Share

  26. COBBINAH P, Zheng Zheng S, Oklah F, Yuyang Z, et al
    Comparative analysis of Paiteling a traditional Chinese medicine (TCM) and CO2 laser therapy for high-risk HPV-associated with LSIL (CIN1) lesions.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:81-86.
    >> Share

  27. KIRSTINE HANSEN L, Shennan AH, Louise Eisland-Schmidt Christiansen E, Tydeman G, et al
    Transvaginal cervical cerclage - How well do surgeons assess their own procedures?
    Eur J Obstet Gynecol Reprod Biol. 2024;302:268-272.
    >> Share

  28. MASJEDI M, Izadi Y, Montahaei T, Mohammadi R, et al
    An illustrated review on herbal medicine used for the treatment of female infertility.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:273-282.
    >> Share

  29. FERREIRA DE CASTRO L, Santos I, Lagana AS, de Vree B, et al
    Enhancing precision in hysteroscopic surgery: The role of intraoperative ultrasound.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:306-309.
    >> Share

  30. GARDELLA B, Cassani C, Dominoni M, Pasquali MF, et al
    Maintenance pharmacological therapy of recurrent vulvovaginal candidiasis. A Bayesian network meta-analysis of randomized studies.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:310-316.
    >> Share

  31. VAN CAUWENBERGH O, Willers N, Vandenbroucke T, Neven P, et al
    Sexuality after breast cancer treatment: A physician's survey of current clinical practice.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:317-324.
    >> Share

  32. MCGEE AE, Hawco S, Bhattacharya S, Hanley SJB, et al
    Alternatives to surveillance for persistent human papillomavirus after a positive cervical screen: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:332-338.
    >> Share


    Fertil Steril

  33. LEE IT, Wu J, Koelper N, Mumford SL, et al
    Prediction of Menstrual Cycle Phase Using Cross-Sectional Measurements of Reproductive Hormones.
    Fertil Steril. 2024 Oct 17:S0015-0282(24)02309.
    >> Share


  34. Position statement on nurses performing focused ultrasound examinations in a gynecology or infertility setting.
    Fertil Steril. 2024 Oct 18:S0015-0282(24)02241.
    >> Share

  35. KUTTEH WH, Papas RS, Dahdouh EM
    Is it time for New Guidelines for Recurrent Pregnancy Loss integrating Genetic Testing of Products of Conception and Preimplantation Genetic Testing?
    Fertil Steril. 2024 Oct 16:S0015-0282(24)02302.
    >> Share

  36. DONNEZ J, Dolmans MM
    Is allotransplantation of ovarian cortex using immunosuppressive therapy really indicated?
    Fertil Steril. 2024 Oct 15:S0015-0282(24)02305.
    >> Share

  37. WANG C, Lue Y, Swerdloff RS, Morris D, et al
    Use of at-home sperm concentration testing in a male hormonal contraceptive efficacy clinical trial.
    Fertil Steril. 2024 Oct 10:S0015-0282(24)02298.
    >> Share


    Gynecol Endocrinol

  38. LOKSHIN VN, Temirkhanovna Abshekenova A, Di Renzo GC, Feichtinger M, et al
    Cytoplasmic sperm injection (ICSI) - A systematic review of the literature.
    Gynecol Endocrinol. 2024;40:2414783.
    >> Share

  39. YANG X, Jiang L, Xu Y
    HSD11B1 overexpression in dendritic cells and stromal cells relates to endometriosis by inhibiting dendritic cell proliferation and maturation.
    Gynecol Endocrinol. 2024;40:2411607.
    >> Share

  40. LIHUA C, Hua S, Wenzhan W, Standard J, et al
    Expression and clinical significance of lncRNA PART1 in patients with unexplained recurrent pregnancy loss.
    Gynecol Endocrinol. 2024;40:2375582.
    >> Share


    Gynecol Oncol

  41. SAAB R, Fellman BM, Legarreta AF, Meyer LA, et al
    Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study.
    Gynecol Oncol. 2024;191:143-149.
    >> Share

  42. PLINSINGA ML, Rye S, Jones T, Vagenas D, et al
    Mild symptoms matter: Results from a prospective, longitudinal study on the relationship between symptoms, lymphedema and health-related outcomes post-gynecological cancer.
    Gynecol Oncol. 2024;191:158-164.
    >> Share

  43. OGASAWARA A, Matsushita H, Tan TZ, Shintani D, et al
    Immunological impact of intraperitoneal and intravenous chemotherapy in ovarian cancer, translational analyses of the Phase 3 iPocc trial.
    Gynecol Oncol. 2024;191:124-131.
    >> Share

  44. PERRONE E, Capasso I, Giannarelli D, Trozzi R, et al
    Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis.
    Gynecol Oncol. 2024;191:150-157.
    >> Share


    Int J Cancer

  45. ZHENG Y, Vdovichenko N, Schurmann P, Ramachandran D, et al
    Comparative sequencing study of mismatch repair and homology-directed repair genes in endometrial cancer and breast cancer patients from Kazakhstan.
    Int J Cancer. 2024 Oct 14. doi: 10.1002/ijc.35215.
    >> Share

  46. BIGNOTTI E, Simeon V, Ardighieri L, Kuhn E, et al
    TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study.
    Int J Cancer. 2024 Oct 16. doi: 10.1002/ijc.35203.
    >> Share

  47. MISHRA GA, Pimple SA, Anand KV, Kulkarni VY, et al
    Acceptability and validity of HPV self-sampling for cervical cancer screening among women living in different ecological settings in India.
    Int J Cancer. 2024 Oct 16. doi: 10.1002/ijc.35222.
    >> Share


    Int J Gynaecol Obstet

  48. VASSALLO A, Di Filippo L, Frara S, Bertoli M, et al
    New onset of Graves' disease after controlled ovarian stimulation: A case report and brief literature review.
    Int J Gynaecol Obstet. 2024 Oct 12. doi: 10.1002/ijgo.15951.
    >> Share

  49. BENSELER A, Vicus D, Covens A, Kupets R, et al
    Assessing para-aortic nodal status in high-grade endometrial cancer patients with negative pelvic sentinel lymph node biopsy.
    Int J Gynaecol Obstet. 2024 Oct 14. doi: 10.1002/ijgo.15937.
    >> Share

  50. SADAT R, Sacinti KG, Topcu EG, Saeed S, et al
    Overcoming barriers to cervical cancer prevention in Afghanistan: The imperative for an HPV vaccination and screening program.
    Int J Gynaecol Obstet. 2024 Oct 16. doi: 10.1002/ijgo.15956.
    >> Share

  51. MOR-HADAR D, Wilailak S, Berek J, McNally OM, et al
    FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy.
    Int J Gynaecol Obstet. 2024 Oct 16. doi: 10.1002/ijgo.15884.
    >> Share

  52. VANHAREN Y, Knollenburg L, Van Berendoncks A, Mannaerts D, et al
    Unveiling women's lived experiences with care provided by a pregnancy heart team: A qualitative phenomenological study.
    Int J Gynaecol Obstet. 2024 Oct 16. doi: 10.1002/ijgo.15968.
    >> Share

  53. KARATAS E, Tanacan A, Ozkavak OO, Serbetci H, et al
    Outcomes of pregnancies diagnosed with absent or abnormal fetal gallbladder in a tertiary center.
    Int J Gynaecol Obstet. 2024 Oct 18. doi: 10.1002/ijgo.15949.
    >> Share

  54. JIANG Y, Chen X, Li S, Huang C, et al
    Maternal serum Numb in the first trimester of pregnancy as a biomarker for early prediction of pre-eclampsia: A prospective cohort study.
    Int J Gynaecol Obstet. 2024 Oct 19. doi: 10.1002/ijgo.15971.
    >> Share

  55. ABOKAF H, Korytnikova E, Yaniv-Salem S, Shoham-Vardi I, et al
    Pregnancy outcomes following second-trimester abortions: A comparison between medical and surgical management. A historic cohort study.
    Int J Gynaecol Obstet. 2024 Oct 19. doi: 10.1002/ijgo.15958.
    >> Share

  56. MUNYAKARAMA B, Koushik A, Leduc V, Healy-Profitos J, et al
    Association of gestational trophoblastic disease with subsequent development of non-trophoblastic cancer.
    Int J Gynaecol Obstet. 2024 Oct 19. doi: 10.1002/ijgo.15976.
    >> Share

  57. NASSER BH, Jadaon JE, Awad-Khamaisy N, Lfoul LA, et al
    Novel risk factors associated with retained placenta after vaginal birth.
    Int J Gynaecol Obstet. 2024 Oct 19. doi: 10.1002/ijgo.15978.
    >> Share

  58. XU ZM, Lin D, Zhang J, Zheng YJ, et al
    A comparison of Mersilene tape versus braided suture in transvaginal cervical cerclage: A retrospective case-control study.
    Int J Gynaecol Obstet. 2024;167:743-752.
    >> Share


    Int J Radiat Oncol Biol Phys

  59. MURATA K, Okonogi N, Ando K, Tsuchida K, et al
    Carbon-ion radiotherapy for adenocarcinoma of the uterine cervix: clinical outcomes of a multicenter prospective registry-based study in Japan (2016-2020).
    Int J Radiat Oncol Biol Phys. 2024 Oct 16:S0360-3016(24)03467.
    >> Share


    J Clin Endocrinol Metab

  60. KAMPMANN U, Suder LB, Nygaard M, Geiker NRW, et al
    Pre-pregnancy and gestational interventions to prevent childhood obesity.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae724. doi: 10.1210.
    >> Share

  61. SILVA EL, Lane KJ, Cheng JJ, Popp Z, et al
    Polycystic ovary syndrome underdiagnosis patterns by individual-level and spatial social vulnerability measures.
    J Clin Endocrinol Metab. 2024 Oct 12:dgae705. doi: 10.1210.
    >> Share


    J Clin Oncol

  62. BERGSTROM EN, Abbasi A, Diaz-Gay M, Galland L, et al
    Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides.
    J Clin Oncol. 2024;42:3550-3560.
    >> Share

  63. CHLEBOWSKI RT, Aragaki AK, Pan K, Haque R, et al
    Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials.
    J Clin Oncol. 2024;42:3537-3549.
    >> Share


    JAMA

  64. MORCH LS, Meaidi A, Corn G, Hargreave M, et al
    Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems.
    JAMA. 2024 Oct 16. doi: 10.1001/jama.2024.18575.
    >> Share


    Lancet

  65. SUN C, Ma D
    Embracing more treatment choices for metastatic, recurrent, or persistent cervical cancer.
    Lancet. 2024 Oct 15:S0140-6736(24)02196-2. doi: 10.1016/S0140-6736(24)02196.
    >> Share

  66. DUSKA LR, Randall LM
    Progress in the treatment paradigms for locally advanced cervical cancer.
    Lancet. 2024;404:1494-1496.
    >> Share

  67. MCCORMACK M, Eminowicz G, Gallardo D, Diez P, et al
    Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.
    Lancet. 2024;404:1525-1535.
    >> Share

  68. WU X, Sun Y, Yang H, Wang J, et al
    Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China.
    Lancet. 2024 Oct 15:S0140-6736(24)02135-4. doi: 10.1016/S0140-6736(24)02135.
    >> Share


    Obstet Gynecol

  69. IBARRA AJ, Butters MA, Catov JM, Ackenbom MF, et al
    Association Between Hypertensive Disorders of Pregnancy and Interval Neurocognitive Decline: An Analysis of the Hispanic Community Health Study/Study of Latinos.
    Obstet Gynecol. 2024;144:e107-e108.
    >> Share

  70. DURNWALD C, Beck RW, Li Z, Norton E, et al
    Continuous Glucose Monitoring-Derived Differences in Pregnancies With and Without Adverse Perinatal Outcomes.
    Obstet Gynecol. 2024;144:684-696.
    >> Share


  71. Placenta Accreta Spectrum: Correction.
    Obstet Gynecol. 2024;144:e111.
    >> Share

  72. VIANA PINTO P, Majd HS
    Prophylactic Radiologic Interventions for Postpartum Hemorrhage Control in Women with Placenta Accreta Spectrum Disorder a Systematic Review and Meta-analysis.
    Obstet Gynecol. 2024;144:e108.
    >> Share

  73. ZERA C
    Diabetic Ketoacidosis in Pregnancy: A Call to Eliminate Preventable Complications.
    Obstet Gynecol. 2024;144:577-578.
    >> Share


    Oncogene

  74. LI Y, Yang H, Li A, Chen B, et al
    CypA/TAF15/STAT5A/miR-514a-3p feedback loop drives ovarian cancer metastasis.
    Oncogene. 2024 Oct 14. doi: 10.1038/s41388-024-03188.
    >> Share

  75. SHI J, Zhou R, Wang S, Liu Y, et al
    NEU4-mediated desialylation enhances the activation of the oncogenic receptors for the dissemination of ovarian carcinoma.
    Oncogene. 2024 Oct 14. doi: 10.1038/s41388-024-03187.
    >> Share

  76. SAKAUE T, Dorayappan KDP, Zingarelli R, Khadraoui W, et al
    Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin.
    Oncogene. 2024 Oct 16. doi: 10.1038/s41388-024-03182.
    >> Share


    PLoS One

  77. SUTHERLAND EK, Smith JD, Ofori-Boateng M, Kushitor SB, et al
    Study protocol for the development of a real-time interface showing the availability of breast and cervical cancer services in Ghana.
    PLoS One. 2024;19:e0312150.
    >> Share

  78. YI ZY, Liang QX, Zhou Q, Yang L, et al
    Maternal total sleep deprivation causes oxidative stress and mitochondrial dysfunction in oocytes associated with fertility decline in mice.
    PLoS One. 2024;19:e0306152.
    >> Share


    Proc Natl Acad Sci U S A

  79. ROLLIN FG, Patel SA, McCachren SS
    Contextualizing racial associations in gene expression in patients with uterine serous carcinoma.
    Proc Natl Acad Sci U S A. 2024;121:e2418977121.
    >> Share

  80. KIM JJ, Simon M, Fleming G
    Reply to Rollin et al.: Clarifying the multifactorial origins of racial disparities in uterine serous carcinoma.
    Proc Natl Acad Sci U S A. 2024;121:e2419163121.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016